A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1997
11/27/1997	WO1997039102A3 Secreted proteins
11/27/1997	WO1997038665A3 Inhibitors of farnesyl-protein transferase
11/27/1997	WO1997035976A3 Epidermal differentiation factor
11/27/1997	CA2255906A1 Human interleukin-1j and antagonists thereof
11/27/1997	CA2255888A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/27/1997	CA2255650A1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
11/27/1997	CA2254768A1 Antagonists of gonadotropin releasing hormone
11/27/1997	CA2253934A1 Inhibitors of protein farnesyl transferase
11/27/1997	CA2253342A1 Biphenylsulfonamide matrix metalloproteinase inhibitors
11/27/1997	CA2252537A1 Benzofuran carboxamides and their therapeutic use
11/27/1997	CA2252531A1 Quinoline carboxamides as tnf inhibitors and as pde-iv inhibitors
11/27/1997	CA2252501A1 Quinoline sulfonamides as tnf inhibitors and as pde-iv inhibitors
11/26/1997	EP0808838A1 Sulfur-containing heterocyclic bradykinin antagonists, processes for their production and use thereof
11/26/1997	EP0808833A2 Vitamin D3 analogs
11/26/1997	EP0808832A2 Fluorinated vitamin D3 analogs
11/26/1997	EP0808831A2 Fluorinated vitamin D3 analogs
11/26/1997	EP0808628A2 Use of non-peptide bradykinin antagonists for treating and preventing chronic fibrogenetic liver diseases, acute liver diseases and complications thereof
11/26/1997	EP0808627A2 Use of non-peptide bradykinin antagonists for treating and preventing chronic fibrogenetic liver diseases, acute liver diseases and complications thereof
11/26/1997	EP0808369A1 GnRH-LEUKOTOXIN CHIMERAS
11/26/1997	EP0808328A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
11/26/1997	EP0808323A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF
11/26/1997	EP0808318A1 Tricyclic substituted hexahydrobenz e]isoindole alpha-1 adrenergic antagonists
11/26/1997	EP0808312A1 Indole derivatives as 5-ht receptor antagonist
11/26/1997	EP0808309A1 Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors
11/26/1997	EP0808307A1 Bicyclic isothiourea derivatives useful in therapy
11/26/1997	EP0808171A2 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
11/26/1997	EP0808169A1 Programmed cell death genes and proteins
11/26/1997	EP0808166A1 Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness
11/26/1997	EP0808165A1 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists
11/26/1997	EP0808164A1 Method for treatment of obesity using prolactin modulators and diet
11/26/1997	EP0808103A1 Protein hydroxylation inhibitors for fibroproliferative disorders
11/26/1997	EP0719271B1 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
11/26/1997	EP0686037A4 Hormone replacement therapy
11/26/1997	EP0662130B1 A method of producing hepatocyte growth factor and a cell line
11/26/1997	CN1166173A Tetrahydropyridine-(or 4-hydroxypiperidine) Alkylazoles having an affinity for sigma and/or 5HTIA receptors
11/26/1997	CN1166167A Novel prostaglandin synthase inhibitors
11/26/1997	CN1165817A New inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them
11/26/1997	CN1165655A Method of treating conditions with estrogen agonists
11/26/1997	CN1165654A Combination therapy to treat osteoporosis-polyphosphonates or progesting and extrogen agonists
11/26/1997	CN1165651A Use of (E)-1£4'-(2-alkylaminoethioxy) phenyl\|-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions
11/26/1997	CN1165649A Method of increasing testostrone
11/25/1997	US5691448 Glutamic acid decarboxylase protein for autoantibody binding to epitopes
11/25/1997	US5691382 Enzyme inhibitors for cardiovascular disorders
11/25/1997	US5691381 Antagonist of tumor necrosis factor, antiinflammatory agent, antiarthritic agent
11/25/1997	US5691379 Dihydrolipoic acid as an ophthalmological agent to suppress intolerance reactions in the area between implants and living body tissue
11/25/1997	US5691375 Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
11/25/1997	US5691374 Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors
11/25/1997	US5691373 Nonpeptide endothelin antagonists I
11/25/1997	US5691372 Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
11/25/1997	US5691371 Antitumor and -carcinogenic agents; prodrugs bioreduced to release a cytotoxin, a mechlorethamine derivative; water soluble
11/25/1997	US5691370 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2-adrenoceptor agonists
11/25/1997	US5691368 Therapy for neurodegenerative disorders
11/25/1997	US5691358 4-amino-n-(4-methyl-4-piperidinyl)-2-methoxybenzamides
11/25/1997	US5691355 Syneristic mixture; therapy for breast cancer
11/25/1997	US5691353 Method of inhibiting aortal smooth muscle cell proliferation using naphthyl compounds
11/25/1997	US5691348 Pyridyl imidazole derivatives and processes for the preparation thereof
11/25/1997	US5691347 Angiotensin ii inhibitors and vasoconstriction
11/25/1997	US5691340 Benzopyran derivatives
11/25/1997	US5691306 Protein secretion
11/25/1997	US5691186 Filariid cysteine protease genes
11/25/1997	US5691182 Use of isolated domains of type IV collagen to modify cell and tissue interactions
11/25/1997	US5690944 Cosmetic compositions containing lactate dehydrogenase inhibitors
11/22/1997	CA2205785A1 Sulfur-containing heterocyclic bradykinin antagonists, process for their preparation, and their use
11/22/1997	CA2205780A1 Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith
11/20/1997	WO1997043412A1 Novel agouti-related gene
11/20/1997	WO1997043408A1 Anti-human mp52 monoclonal antibody
11/20/1997	WO1997043311A1 Anticoagulant peptide fragments derived from apolipoprotein b-100
11/20/1997	WO1997043288A1 Novel imidazopyridines
11/20/1997	WO1997043287A1 Carboline derivatives
11/20/1997	WO1997043278A1 Somatostatin agonists and antagonists
11/20/1997	WO1997043276A1 Novel 2,3 disubstituted-4(3h)-quinazolinones
11/20/1997	WO1997043271A1 Alkylaminobenzothiazole and -benzoxazole derivatives
11/20/1997	WO1997043260A1 Indole derivatives useful as endothelin receptor antagonists
11/20/1997	WO1997043259A1 Arylalkylpiperazine compounds as antioxidants
11/20/1997	WO1997043250A1 Hydroxamic acid based inhibitors of the formation of cd23 and tnf
11/20/1997	WO1997043249A1 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF
11/20/1997	WO1997043247A1 Inhibition of matrix metalloproteases by substituted phenethyl compounds
11/20/1997	WO1997043245A1 Inhibition of matrix metalloproteases by acetylene containing compounds
11/20/1997	WO1997043240A1 INHIBITION OF MATRIX METALLOPROTEASES BY 2-(φ-AROYLALKYL)-4-BIARYL-OXOBUTYRIC ACIDS
11/20/1997	WO1997043239A1 Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids
11/20/1997	WO1997043238A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors
11/20/1997	WO1997043237A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
11/20/1997	WO1997043235A1 Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same
11/20/1997	WO1997042969A1 USE OF IL-12 AND IFN-α FOR THE TREATMENT OF INFECTIOUS DISEASES
11/20/1997	WO1997042939A1 Liposomal antineoplaston therapies with markedly improved antineoplastic activity
11/20/1997	WO1997035538A3 Tumor necrosis factor alpha convertase
11/20/1997	WO1997026017A3 Perfluoroalkyl-containing metal complexes and their use in nmr diagnostics
11/20/1997	CA2255589A1 Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same
11/20/1997	CA2254857A1 Anti-human mp52 monoclonal antibody
11/20/1997	CA2253876A1 Indole derivatives useful as endothelin receptor antagonists
11/20/1997	CA2253590A1 Inhibitors of the production of s-cd23 and the secretion of tnf
11/20/1997	CA2253566A1 Arylalkylpiperazine compounds as antioxidants
11/19/1997	EP0807686A2 Interleukin-1 beta converting enzyme like apoptotic protease-7
11/19/1997	EP0807638A1 Inhibitors and substrates of thrombin
11/19/1997	EP0807633A2 Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
11/19/1997	EP0807628A1 Aromatic compound and pharmaceutical composition
11/19/1997	EP0807627A2 Anilide compounds as ACAT inhibitors
11/19/1997	EP0807624A2 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
11/19/1997	EP0807439A2 Method of treating sepsis and adult respiratory distress syndrome
11/19/1997	EP0807437A1 Polyacrylilic and polymethacrylic acid containing compositions with antiadhesion properties

1 ... 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 ... 1564